Healthcare: The One Big Thing to Watch at ASCO 2018 Next Week
Industry Focus - Un podcast de The Motley Fool
Catégories:
Precision medicines from Loxo Oncology and Blueprint Medicines could take center stage at the most important cancer conference of the year. Also, here’s why Abiomed’s shares have doubled in 2018. (LOXO) (BPMC) (ABMD)
